The amplification or transcriptional upregulation of GATA6, as well as activation of the WNT signaling pathway, can improve the overall survival rate of human pancreatic ductal carcinoma (PDAC) at advanced malignant stages. This evidence concerns the gene GATA6 and pancreatic ductal adenocarcinoma.